LDDD · XBRL financial data

Longduoduo Company financial statements, every fiscal year

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LDDD's year ends in late June)

In thousands of dollars	FY 2022Jun 30, 2022	FY 2023†Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Revenue	3,238	3,819	7,390	4,263	1,822
Cost of revenue	1,005	592	173	91	17
Cost of goods and services sold	929	592	—	—	—
Gross profit	2,233	3,227	7,216	4,172	1,805
Selling, general and administrative	9,788	3,197	5,190	3,619	2,439
Total operating expenses	60	60	92	128	101
Operating income (loss)	(7,555)	29	2,026	553	(633)
Other income (expense)	(7)	2	(140)	162	—
Income tax expense (benefit)	2	10	523	222	66
Net income (loss)	(7,564)	(39)	1,255	460	(579)
Earnings per share, basic USD per share	(0.03)	(0.00)	0.04	0.02	(0.02)
Earnings per share, diluted USD per share	(0.03)	(0.00)	0.04	0.02	(0.02)
Weighted average shares, basic thousands of shares	256,169	30,018	30,005	30,010	30,015
Weighted average shares, diluted thousands of shares	256,169	30,018	30,005	30,010	30,015

† Share count changed about 1/10 in the period ending 2023-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (LDDD's year ends in late June)

In thousands of dollars	FY 2022Jun 30, 2022	FY 2023†Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Cash and cash equivalents	357	1,137	1,404	1,643	1,589
Inventory	3	1	—	—	—
Total current assets	424	1,313	1,660	1,814	1,784
Property and equipment, net	109	153	353	280	213
Right-of-use asset	77	13	50	33	66
Total assets	611	1,483	2,063	2,126	2,063
Accounts payable	41	1,044	359	400	403
Accrued liabilities	126	91	50	50	52
Total current liabilities	1,630	2,047	1,264	830	1,283
Lease liability, non-current	3	7	18	—	25
Total liabilities	1,633	2,053	1,283	830	1,308
Accumulated deficit	(7,846)	(7,885)	(6,630)	(6,169)	(6,748)
Total stockholders' equity	(929)	(542)	703	1,185	704
Total liabilities and equity	611	1,483	2,063	2,126	2,063
Common shares outstanding (cover page) thousands of shares	≈300,000	30,005	30,005	30,015	30,015

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.
† Share count changed about 1/10 in the period ending 2023-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (LDDD's year ends in late June)

In thousands of dollars	FY 2022Jun 30, 2022	FY 2023†Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Net income (loss)	(7,564)	(39)	1,255	460	(579)
Stock-based compensation	6,739	385	—	—	—
Net cash from operating activities	29	965	582	277	(163)
Purchases of property and equipment	112	120	305	59	31
Net cash from investing activities	(112)	(126)	(305)	(59)	(31)
Proceeds from issuing common stock	31	—	—	—	—
Net cash from financing activities	180	(143)	—	—	—
Net change in cash	84	780	267	239	(54)

† Share count changed about 1/10 in the period ending 2023-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Longduoduo	1,589	631*	275*	30.0M	—	Q4 FY26 10-KJun 30, 2026
P3 Health Partners	21,272	386,381	(61,914)*	not reported	0.3 quarters	Q2 FY26 10-QJun 30, 2026
Agape ATP	45	109	(110)*	1.0M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Vsee Health	454	1,562	(1,174)*	56.7M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Welsis	0	0	(11)	2.8M	—	Q1 FY26 10-QDec 31, 2025

Not investment advice. Not affiliated with the U.S. SEC.